Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CORE-INJECTOR

K-Number: K221054 · 2022-12-21

Decision Date2022-12-21
Product CodeFBK
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

CORE-INJECTOR is a medical device manufactured by Incore Co., Ltd.. It received FDA 510(k) clearance on 2022-12-21 under approval number K221054. The device is classified under product code FBK. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CORE-INJECTOR?

CORE-INJECTOR is a medical device that received FDA 510(k) clearance on 2022-12-21. It is manufactured by Incore Co., Ltd.. The 510(k) number is K221054.

When was CORE-INJECTOR approved by the FDA?

CORE-INJECTOR received FDA 510(k) clearance on 2022-12-21, under approval number K221054.

What company makes CORE-INJECTOR?

CORE-INJECTOR is manufactured by Incore Co., Ltd..

What is the FDA product code for CORE-INJECTOR?

The FDA product code for CORE-INJECTOR is FBK.

Other Devices by Incore Co., Ltd.

Related Devices (Code: FBK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.